Back
NLS Pharmaceutics Vs. Jabil Industry Stock Comparison
Buy
65
NLSP
NLS Pharmaceutics
Last Price:
0.26
Seasonality Move:
10.57%
Buy
52
JBL
Jabil
Last Price:
109.14
Seasonality Move:
7.32%
Buy
65
NLS Pharmaceutics (NLSP)
is a Buy
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.18. The Score for NLSP is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- NLSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Jabil (JBL)
is a Buy
Is Jabil a Buy, Sell or Hold?
- The current Jabil [JBL] share price is $112.24. The Score for JBL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- JBL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLSP is experiencing slight buying pressure.
JBL Stock Price Chart
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 54.72 | Buy |
Chaikin Money Flow: | 1441391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.13 - 0.19) | Buy |
Bollinger Bands (100): | (0.11 - 0.35) | Sell |
JBL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.34 | Sell |
Relative Strength Index (14 RSI): | 41.33 | Sell |
Chaikin Money Flow: | 591366 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.9 - 120.94) | Sell |
Bollinger Bands (100): | (116.7 - 140.02) | Sell |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.18 | Buy |
20-day SMA: | 0.15 | Buy |
50-day SMA: | 0.15 | Buy |
200-day SMA: | 0.41 | Sell |
8-day EMA: | 0.17 | Buy |
20-day EMA: | 0.16 | Buy |
50-day EMA: | 0.17 | Buy |
200-day EMA: | 0.4 | Sell |
JBL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.85 | Sell |
20-day SMA: | 117.12 | Sell |
50-day SMA: | 118.38 | Sell |
200-day SMA: | 126.37 | Sell |
8-day EMA: | 115.34 | Sell |
20-day EMA: | 116.91 | Sell |
50-day EMA: | 120.02 | Sell |
200-day EMA: | 120.84 | Sell |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Jabil Earnings Growth & JBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.34 per share, a decrease this year of $0.08 per share, and an increase next year of $0.81 per share.
NLS Pharmaceutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Jabil Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |